sulindac
chemical compound
Facts
13 properties- Instance of
- group of stereoisomers
- Subclass of
- chemical compound
- Has use
- medication[5]
- Canonical SMILES
- CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O[3]
- Chemical formula
- C₂₀H₁₇FO₃S[4]
- Isomeric SMILES
- CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
- Mass
- 356.088 Da
- Medical condition treated
- enthesopathy, rheumatoid arthritis, osteoarthritis, inflammation, gout attack, ankylosing spondylitis (1988–present), osteoarthritis (1988–present), rheumatoid arthritis (1988–present)
- Pregnancy category
- Australian pregnancy category C, US pregnancy category C
- Significant drug interaction
- aspirin, nabumetone, naproxen, celecoxib, Diclofenac, piroxicam, meloxicam, (RS)-fenoprofen, (±)-flurbiprofen, ibuprofen, indomethacin, (RS)-ketoprofen[11][12][13][14][15][16][17][18][19][20][21][22][23][24]
+71 more
(RS)-etodolac, clopidogrel, eptifibatide, iloprost, prostacyclin, parecoxib, tirofiban, aceclofenac, tenoxicam, abciximab, prasugrel, ticagrelor, cangrelor, vortioxetine, (S)-duloxetine, paroxetine, sertraline, venlafaxine, fluvoxamine, fluoxetine, (RS)-citalopram, pemetrexed, cyclosporine, methotrexate, rac-warfarin, fondaparinux, heparin, acenocoumarol, phenindione, rivaroxaban, apixaban, enoxaparin, dalteparin, tinzaparin, triamterene, amiloride, eplerenone, spironolactone, methylprednisolone, dexamethasone, prednisolone, prednisone, betamethasone, budesonide, lisinopril dihydrate, valsartan, telmisartan, quinapril, ramipril, captopril, enalapril, trandolapril, eprosartan, irbesartan, candesartan, losartan, perindopril, olmesartan, azilsartan, tacrolimus, (RS)-bendroflumethiazide, chlorthalidone, (2RS,6RS)-clopamide, amitriptyline, imipramine, clomipramine, bumetanide, furosemide, hydrochlorothiazide, indapamide, tenofovir disoproxil - Subject has role
- cyclooxygenase inhibitors, non-steroidal anti-inflammatory drug, antineoplastic, female reproductive toxicant (1999–present), developmental toxicant (1999–present)
- World Health Organisation international non-proprietary name
- sulindac
🏷️ Also known as
en (Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
en cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
en cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid
en cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid
en Clinoril®
en sulindac
en Sulindac
en Sulindaco
en Sulindacum
en (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
ar سولينداك
fa سولینداک
fi Sulindaakki
id Sulindak
ja スリンダク
ru сулиндак
zh 舒林酸
🔖 Identifiers · 38
- OpenAlex ID
- C2776241388
- ATC code
- M01AB02
- CA PROP 65 ID
- sulindac
- CAS Registry Number
- 38194-50-2
- ChEBI ID
- 9352
- ChEMBL ID
- CHEMBL15770
- ChemSpider ID
- 1265915
- CosIng number
- 86394
- DSSTOX compound identifier
- DTXCID703624
- DSSTox substance ID
- DTXSID4023624
- DrugBank ID
- DB00605
- DrugCentral ID
- 2534
Show all 38 identifiers +26
- EC number
- 253-819-2
- ECHA Substance Infocard ID
- 100.048.909
- Freebase ID
- /m/0b_548
- Guide to Pharmacology Ligand ID
- 5425
- Human Metabolome Database ID
- HMDB0014743
- InChIKey
- MLKXDPUZXIRXEP-MFOYZWKCSA-N
- MassBank accession ID
- MSBNK-Keio_Univ-KO004047, MSBNK-Keio_Univ-KO004048, MSBNK-Keio_Univ-KO004049, MSBNK-Keio_Univ-KO004050, MSBNK-Keio_Univ-KO004051, MSBNK-Keio_Univ-KO009077, MSBNK-Keio_Univ-KO009078, MSBNK-Keio_Univ-KO009079, MSBNK-Keio_Univ-KO009080, MSBNK-Keio_Univ-KO009081, MSBNK-Waters-WA002491, MSBNK-Waters-WA002492, MSBNK-Waters-WA002493, MSBNK-Waters-WA002494
- MeSH descriptor ID
- D013467
- MeSH tree code
- D02.455.426.559.847.486.875, D04.615.486.875
- MedlinePlus drug identifier
- a681037
- Microsoft Academic ID (discontinued)
- 2776241388
- NDF-RT ID
- N0000146307
- NSC number
- 757344
- Probes And Drugs ID
- PD001740
- PubChem CID
- 1548887
- Reaxys registry number
- 2951842
- RxNorm CUI
- 10237
- SPLASH
- splash10-0a4i-0019000000-6a9b19701aa1af58166d, splash10-001l-0095000000-1aef30e1f36f3fcc9ea2, splash10-001j-0090000000-4f30705a14fab7bb25e0, splash10-001i-0090000000-8bf873219e6e4353be1e, splash10-000y-0095000000-0a507959838acf3f73cb, splash10-001i-0090000000-62d28a75ad39324bcb9d, splash10-001i-0090000000-dd57b77e6473286ace61, splash10-001i-0090000000-dde0904828e15216b49a, splash10-00lr-0090000000-dcab24328f0e0a3c7cf5, splash10-0a4i-0069000000-be643d55172bd2292511
- SureChEMBL ID
- 4202
- UMLS CUI
- C0038792
- UNII
- 184SNS8VUH
- UniChem compound ID
- 330129
- WikiProjectMed ID
- Sulindac
- WordNet 3.1 Synset ID
- 04360488-n
🔗 Connections
← Significant drug interaction 199
Significant drug interaction 198
← Drug or therapy used for treatment 8
Medical condition treated 7
Subject has role 2
Has use 1
Subclass of 1
Press Enter · cited answer in seconds